miR-34 and p53: New Insights into a Complex Functional Relationship
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-34 and p53: New Insights into a Complex Functional Relationship
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 7, Pages e0132767
Publisher
Public Library of Science (PLoS)
Online
2015-07-16
DOI
10.1371/journal.pone.0132767
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
- (2014) N. Okada et al. GENES & DEVELOPMENT
- miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110
- (2014) Rui Song et al. NATURE
- miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2
- (2014) Jing Y. Krzeszinski et al. NATURE
- Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c
- (2014) Olivia A. Ebner et al. PLoS One
- Oligoasthenoteratozoospermia and Infertility in Mice Deficient for miR-34b/c and miR-449 Loci
- (2014) Stefano Comazzetto et al. PLoS Genetics
- p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells
- (2013) Nam Hee Kim et al. CELL CYCLE
- Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis
- (2013) Arash Javeri et al. MEDICAL ONCOLOGY
- The impact of post-transcriptional regulation in the p53 network
- (2012) J. A. Freeman et al. Briefings in Functional Genomics
- miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
- (2012) Helge Siemens et al. CELL CYCLE
- Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer
- (2012) Claudia Piovan et al. Molecular Oncology
- A transcription activator-like effector toolbox for genome engineering
- (2012) Neville E Sanjana et al. Nature Protocols
- Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop
- (2012) J Zhang et al. ONCOGENE
- MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading Frame
- (2012) Pooja Mandke et al. PLoS One
- Intact p53-Dependent Responses in miR-34–Deficient Mice
- (2012) Carla P. Concepcion et al. PLoS Genetics
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- MicroRNA-449 in cell fate determination
- (2011) Muriel Lizé et al. CELL CYCLE
- miR-605joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress
- (2011) Jiening Xiao et al. EMBO JOURNAL
- A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition
- (2011) Nam Hee Kim et al. JOURNAL OF CELL BIOLOGY
- p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
- (2011) Taewan Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genome-wide Characterization ofmiR-34aInduced Changes in Protein and mRNA Expression by a Combined Pulsed SILAC and Microarray Analysis
- (2011) Markus Kaller et al. MOLECULAR & CELLULAR PROTEOMICS
- Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription
- (2011) Feng Zhang et al. NATURE BIOTECHNOLOGY
- miR-34 miRNAs provide a barrier for somatic cell reprogramming
- (2011) Yong Jin Choi et al. NATURE CELL BIOLOGY
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting
- (2011) Tomas Cermak et al. NUCLEIC ACIDS RESEARCH
- Capture of MicroRNA–Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor Signaling
- (2011) Ashish Lal et al. PLoS Genetics
- Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
- (2010) Flavia Pichiorri et al. CANCER CELL
- Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34a
- (2010) Qing-Rong Chen et al. JOURNAL OF PROTEOME RESEARCH
- A TALE nuclease architecture for efficient genome editing
- (2010) Jeffrey C Miller et al. NATURE BIOTECHNOLOGY
- Role of miR-34c microRNA in the late steps of spermatogenesis
- (2010) F. Bouhallier et al. RNA
- miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53
- (2009) F. Navarro et al. BLOOD
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC
- (2009) N R Christoffersen et al. CELL DEATH AND DIFFERENTIATION
- The miR-34 family in cancer and apoptosis
- (2009) H Hermeking CELL DEATH AND DIFFERENTIATION
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Tumor Suppressive Functions of p53
- (2009) J. T. Zilfou et al. Cold Spring Harbor Perspectives in Biology
- Acetylation Is Indispensable for p53 Activation
- (2008) Yi Tang et al. CELL
- Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest
- (2008) Fang Sun et al. FEBS LETTERS
- A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene
- (2008) K. A. Cole et al. MOLECULAR CANCER RESEARCH
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
- miR-34a repression of SIRT1 regulates apoptosis
- (2008) M. Yamakuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started